免疫荧光联合免疫印迹提高肌炎自身抗体检测特异性
本研究纳入104例肌无力/肌痛且免疫印迹至少一种肌炎特异性自身抗体(MSA)阳性的患者,检测抗核抗体(ANA)免疫荧光模型。83例确诊特发性炎症性肌病(IIM),其中59% ANA模型与MSA结果一致,非IIM组仅19%(P<0.001);MSA单阳性在IIM组占91.6%,非IIM组61.9%(P=0.0005)。结论认为结合ANA模型可提高免疫印迹检测MSA的特异性。
要点
- 免疫印迹MSA阳性者中,ANA荧光模型与MSA一致在IIM组显著高于非IIM组(59% vs 19%,P<0.001)。
- MSA单阳性与IIM诊断显著相关(91.6% vs 61.9%,P=0.0005)。
- 结合ANA荧光模型有助于提高免疫印迹检测MSA的特异性并辅助诊断MSA相关IIM。
核心结论
- 同时考虑MSA免疫印迹结果及其对应的ANA荧光模型可能有助于提高免疫印迹检测MSA的特异性,并确认MSA相关IIM的诊断。
- MSA单阳性是验证免疫印迹结果的重要附加工具。
研究设计与样本
- 回顾性检测104例表现为肌无力/肌痛且免疫印迹至少一种MSA阳性的患者血清,检测HEp-2000细胞上的ANA。
- 采用卡方检验分析IIM组与非IIM组中MSA结果与对应ANA模型的一致性。
主要发现
- 104例中83例确诊为肯定IIM,21例为其他自身免疫病或各种非系统性疾病。
- MSA单阳性在IIM组占91.6%,非IIM组占61.9%(P=0.0005)。
关键数值与推荐
- MSA检测采用MYOS12 Diver和MIOS7 Diver(D-tek)免疫印迹法。
- ANA检测采用HEp-2000细胞(Immuno Concepts)免疫荧光法。
- MSA单阳性率IIM组91.6%,非IIM组61.9%,P=0.0005。
临床怎么用
- 对免疫印迹MSA阳性但临床不典型的患者,应结合ANA荧光模型一致性判断结果可靠性。
- MSA单阳性可作为支持IIM诊断的附加验证指标。
局限性
- 原文未报告研究设计类型、样本来源、盲法及多中心验证等局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Immunoblot (IB) methods are widely used to detect myositis-specific autoantibodies (MSAs); however, false-positive results are common. In this study, we aimed to determine whether associating the anti-nuclear antibody (ANA) IIF pattern may help to improve the specificity of MSA detection by IB in patients with idiopathic inflammatory myositis (IIM). METHODS: Serum samples from 104 patients presenting with muscle weakness/myalgia and positive to at least one MSA by IB (MYOS12 Diver and MIOS7 Diver, D-tek) were tested for ANAs on HEp-2000 cells (Immuno Concepts). The chi-square test was used to analyse the concordance of the MSA result and its corresponding pattern by ANA testing between patients with and without IIM. RESULTS: Eighty-three of the 104 patients had a diagnosis of definite IIM, while in 21 cases, patients were affected by other autoimmune diseases or various non-systemic diseases. Forty nine of 83 (59%) patients in the IIM group and 4/21 (19%) in the non-IIM group showed a concordance between ANA pattern and MSAs by IB (P < 0.001). MSA monopositivity was significantly associated with IIM (91.6%) compared with 61.9% in the non-IIM group (P = 0.0005). CONCLUSIONS: Considering both the MSA result and its corresponding pattern by ANA testing may help to improve the specificity of MSA detection by IB and to confirm the diagnosis of MSA-associated IIM. The monopositivity of MSAs is an important additional tool to validate IB results.
引用
- Infantino M, Tampoia M, Fabris M, et al. Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis. Rheumatology (Oxford). 2019. PMID: 30726990. doi:10.1093/rheumatology/key451
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。